Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells
Authors:
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 95 (2) , 98-109
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Pfizer
- National Natural Science Foundation of China (81473277)
This publication has 43 references indexed in Scilit:
- Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials, 2013
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceBiochemical Pharmacology, 2012
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxiaProceedings of the National Academy of Sciences, 2012
- Dopamine Blocks Stress-Mediated Ovarian Carcinoma GrowthClinical Cancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell CharacteristicsJNCI: Journal of the National Cancer Institute, 2010
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsProceedings of the National Academy of Sciences, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997